PBM
PBM
NASDAQ · Biotechnology

Psyence Biomedical Ltd

$3.13
+0.24 (+8.30%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 462.8K 474.7K 442.2K
Net Income -17,156 -18,549 -17,491
EPS
Profit Margin -3.7% -3.9% -4.0%
Rev Growth +1.4% -0.9% -6.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 346.6K 417.6K 399.9K
Total Equity 1.19M 1.15M 1.08M
D/E Ratio 0.29 0.36 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -38,868 -39,496 -31,996
Free Cash Flow -11,585 -14,526 -17,935